Why investors are choosing
the Edmonton Region
Research Expertise
Home to Canada’s largest consortium of virologists and research facilities*, the region is at the forefront of life sciences innovation.
World-class Talent
With 19 medical research centers at the University of Alberta and a highly educated workforce, the region offers a skilled talent pool for pharmaceutical companies.
Manufacturing Infrastructure
The region offers a cost-effective environment for pharmaceutical manufacturing with an average cost of $30 per sq. ft. for lab space and the Edmonton Research Park, a 243-acre innovation hub, provides advanced facilities and collaborative spaces tailored for life sciences companies.
Logistics Excellence
Edmonton International Airport is Canada’s first and only CEIV Pharma-certified airport with 24-hour uninterrupted operations, ensuring seamless transport for sensitive pharmaceutical products and making it an ideal hub for manufacturing and exporting pharmaceutical products worldwide.
*The region is home to world-class research facilities including the the Prairies Research Hub for Pandemic Preparedness, Alberta Diabetes Institute, Li Ka Shing Institute of Virology (LKSIoV), Canadian Critical Drug Initiative(CCDI), the Cross Cancer institute, Alberta Machine Intelligence Institute, and more.
The Best Investment
in North America
The Edmonton Region is simply the greatest place to invest in pharmaceutical projects and health advancements. The region’s competitive advantages, like low cost of living, a future-focused workforce, and an established life sciences sector means accelerated results.
Business Tax Rates in Select North American Cities (2021)
USA
Andrew MacIsaac
CEO, Applied Pharmaceutical Innovation (API)
Trusted by
Let’s
connect
The Edmonton Region is the place to invest in the future. Get in touch today to learn more and connect with us at Arab Health 2025.
